DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
+18.6%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$6.69B
AUM Growth
+$682M
(+11%)
Cap. Flow
-$874M
Cap. Flow
% of AUM
-13.05%
Top 10 Holdings %
Top 10 Hldgs %
54.02%
Holding
681
New
246
Increased
85
Reduced
72
Closed
235
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
+$72.1M |
| 2 |
Indivior
INDV
|
+$49.7M |
| 3 |
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
|
+$45.7M |
| 4 |
Merus
MRUS
|
+$32.9M |
| 5 |
Viatris
VTRS
|
+$30.2M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$102M |
| 2 |
Surgery Partners
SGRY
|
+$94.4M |
| 3 |
Catalyst Pharmaceutical
CPRX
|
+$57.6M |
| 4 |
BioNTech
BNTX
|
+$49.8M |
| 5 |
Integra LifeSciences
IART
|
+$42.8M |
Sector Composition
| 1 | Healthcare | 87.45% |
| 2 | Industrials | 0.72% |
| 3 | Technology | 0.55% |
| 4 | Financials | 0.42% |
| 5 | Consumer Discretionary | 0.34% |
